LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
Podcasts & Webcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
BioCentury-BayHelix China Healthcare Summit
East-West Healthcare Reception
BioCentury-BayHelix East-West Summit
Bio€quity Europe
BioCentury Grand Rounds Inquiry
The BioCentury Show
Webinars - Upcoming & On-Demand
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
Exopharm Ltd.
Headquarters:
Melbourne, Australia
Website:
https://exopharm.com
Year Founded:
2013
Status:
Public
Industry Sector:
CommercialServices
CEO:
Jason Alan Carroll, MBA
Number Of Employees:
N/A
Enterprise Value:
$3,515,337
PE Ratio:
-2.88
Exchange/Ticker 1:
ASX:EX1
Exchange/Ticker 2:
N/A
Latest Market Cap:
$30,123,153
BioCentury
|
Apr 7, 2023
Management Tracks
CFO Rajavelu resigns at Fulcrum
Plus: New CBO at Biorchestra, and updates from Cystic Fibrosis Foundation and Qnovia
Read More
BioCentury
|
May 2, 2022
Emerging Company Profile
Mermaid: taking antibodies below the cell surface
Australian-German newco is delivering antibody therapies inside liver cells by encoding them as mRNA
Read More
BioCentury
|
Nov 18, 2021
Deals
China Summit Highlights: Real-world evidence, medtech and deals
Biotech leaders from three continents, Debra Yu, Henk Joos and David Oxley, discuss RWE, medtech, precision medicine and China’s role in global deals
Read More
BioCentury
|
Oct 6, 2021
Management Tracks
Weinstein becomes CFO at Caris Life Sciences
Plus: Kezar, PDS, aTyr, Rosewell, Orum and more
Read More
Items per page:
10
1 - 4 of 4